Danish drugmaker to acquire three manufacturing sites as its controlling shareholder buys US company Catalent
Novo Nordisk strikes $11bn deal to expand production of weight loss drugs
Recent Posts
- Anthropic accuses Alibaba of obtaining ‘illicit’ access to Claude
- Qualcomm reveals Meta as first Big Tech customer for data centre chips
- Micron profits soar nearly 1,400% amid global memory chip shortage
- Predictions market Kalshi in talks to raise funds at $40bn valuation
- Credible deterrence requires a new Nato bank
